Terms: = Head and neck cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Treatment
39 results:
1. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract] [Full Text] [Related]
2. The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of head and neck.
Naito T; Noji R; Kugimoto T; Kuroshima T; Tomioka H; Fujiwara S; Suenaga M; Harada H; Kano Y
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138214
[No Abstract] [Full Text] [Related]
3. PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.
Ferrarotto R; Swiecicki PL; Zandberg DP; Baiocchi RA; Wesolowski R; Rodriguez CP; McKean M; Kang H; Monga V; Nath R; Palmisiano N; Babbar N; Sun W; Hanna GJ
Oral Oncol; 2024 Feb; 149():106634. PubMed ID: 38118249
[TBL] [Abstract] [Full Text] [Related]
4. Current diagnosis and treatment of salivary gland-type tumors of the lung.
Horio Y; Kuroda H; Masago K; Matsushita H; Sasaki E; Fujiwara Y
Jpn J Clin Oncol; 2024 Mar; 54(3):229-247. PubMed ID: 38018262
[TBL] [Abstract] [Full Text] [Related]
5. A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
Ho AL; Foster NR; Deraje Vasudeva S; Katabi N; Antonescu CR; Frenette GP; Pfister DG; Erlichman C; Schwartz GK
Cancer; 2024 Mar; 130(5):702-712. PubMed ID: 37947157
[TBL] [Abstract] [Full Text] [Related]
6. Cell-type-specific tumour sensitivity identified with a bromodomain targeting PROTAC in adenoid cystic carcinoma.
Rose AJ; Fleming MM; Francis JC; Ning J; Patrikeev A; Chauhan R; Harrington KJ; Swain A
J Pathol; 2024 Jan; 262(1):37-49. PubMed ID: 37792636
[TBL] [Abstract] [Full Text] [Related]
7. A Review of the Molecular Landscape of Adenoid Cystic Carcinoma of the Lacrimal Gland.
Powell SK; Kulakova K; Kennedy S
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762061
[TBL] [Abstract] [Full Text] [Related]
8. Pulmonary adenoid cystic carcinoma: molecular characteristics and literature review.
Chen Z; Jiang J; Fan Y; Lu H
Diagn Pathol; 2023 May; 18(1):65. PubMed ID: 37198615
[TBL] [Abstract] [Full Text] [Related]
9. Updated Salivary Gland Immunohistochemistry: A Review.
Swid MA; Li L; Drahnak EM; Idom H; Quinones W
Arch Pathol Lab Med; 2023 Dec; 147(12):1383-1389. PubMed ID: 37074867
[TBL] [Abstract] [Full Text] [Related]
10. Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway.
Zhou MJ; Yang JJ; Ma TY; Feng GX; Wang XL; Wang LY; Ge YZ; Gao R; Liu HL; Shan L; Kong L; Chen XH
Exp Mol Med; 2023 Mar; 55(3):597-611. PubMed ID: 36879115
[TBL] [Abstract] [Full Text] [Related]
11. COX-2 strengthens the effects of acid and bile salts on human esophageal cells and Barrett esophageal cells.
Jiangang S; Nayoung K; Hongfang W; Junda L; Li C; Xuefeng B; Mingsong L
BMC Mol Cell Biol; 2022 Apr; 23(1):19. PubMed ID: 35413817
[TBL] [Abstract] [Full Text] [Related]
12. The Immune Landscape of Chinese head and neck Adenoid Cystic Carcinoma and Clinical Implication.
Dou S; Li R; He N; Zhang M; Jiang W; Ye L; Yang Y; Zhao G; Yang Y; Li J; Chen D; Zhu G
Front Immunol; 2021; 12():618367. PubMed ID: 34552580
[TBL] [Abstract] [Full Text] [Related]
13. A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.
Hanna GJ; ONeill A; Cutler JM; Flynn M; Vijaykumar T; Clark JR; Wirth LJ; Lorch JH; Park JC; Mito JK; Lohr JG; Kaufman J; Burr NS; Zon LI; Haddad RI
Oral Oncol; 2021 Aug; 119():105366. PubMed ID: 34091189
[TBL] [Abstract] [Full Text] [Related]
14. Recent updates in salivary gland tumors of the lung.
Roden AC
Semin Diagn Pathol; 2021 Sep; 38(5):98-108. PubMed ID: 33744018
[TBL] [Abstract] [Full Text] [Related]
15. Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma.
Lorini L; Ardighieri L; Bozzola A; Romani C; Bignotti E; Buglione M; Guerini A; Lombardi D; Deganello A; Tomasoni M; Bonini SA; Sigala S; Farina D; Ravanelli M; Bossi P
Oral Oncol; 2021 Apr; 115():105213. PubMed ID: 33578204
[TBL] [Abstract] [Full Text] [Related]
16. Integrative genomic analysis of salivary duct carcinoma.
Kim Y; Song S; Lee M; Swatloski T; Kang JH; Ko YH; Park WY; Jeong HS; Park K
Sci Rep; 2020 Sep; 10(1):14995. PubMed ID: 32929114
[TBL] [Abstract] [Full Text] [Related]
17. Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.
Hanna GJ; Bae JE; Lorch JH; Schoenfeld JD; Margalit DN; Tishler RB; Haddad RI; Chau NG
Oral Oncol; 2020 Jul; 106():104690. PubMed ID: 32283496
[TBL] [Abstract] [Full Text] [Related]
18. Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation.
Cornett A; Athwal HK; Hill E; Murphy G; Yeoh K; Moskaluk CA; Witt RL; D'Silva NJ; Agarwal S; Lombaert IMA
EBioMedicine; 2019 Mar; 41():175-184. PubMed ID: 30765319
[TBL] [Abstract] [Full Text] [Related]
19. Risk factors for cervical lymph node metastasis in endoscopically resected superficial hypopharyngeal cancers.
Imai T; Ito S; Oikawa T; Asada Y; Matsumoto K; Miyazaki T; Yamazaki T; Satoh I; Noguchi T; Matsuura K
Auris Nasus Larynx; 2019 Jun; 46(3):424-430. PubMed ID: 30249511
[TBL] [Abstract] [Full Text] [Related]
20. Zebrafish blastomere screen identifies retinoic acid suppression of
Mandelbaum J; Shestopalov IA; Henderson RE; Chau NG; Knoechel B; Wick MJ; Zon LI
J Exp Med; 2018 Oct; 215(10):2673-2685. PubMed ID: 30209067
[TBL] [Abstract] [Full Text] [Related]
[Next]
